Biomedical Warming And Thawing Devices Market Research, 2031
The global biomedical warming and thawing devices market size was valued at $159.3 million in 2021, and is projected to reach $376.7 million by 2031, growing at a CAGR of 9.1% from 2022 to 2031. Biomedical warming and thawing devices are used to defrost samples of blood, tissues, cells, and other biologics. Cells and tissues can be successfully and reliably preserved using cryopreservation at lower temperatures, frequently below freezing. Therefore, these biological products must be defrosted before to use. In this situation, biomedical warming and thawing devices is essential since it helps with the warming and defrosting of cryopreserved products. As prolonged exposure to such chemicals may deteriorate the preserved materials' living cells and other components. Biomedical warming and thawing devices lessen the risk that cryo-preservative chemicals may harm these objects. Biomedical warming and thawing devices are necessary for stored cells to stay useful and viable for use in medical treatments.
Growth of the global biomedical warming and thawing devices market size is majorly driven by growing number of blood banks and blood infusion centers, rise in the number of road accidents and trauma cases leading to blood transfusions, and increase in adoption of in-vitro fertilization. Whole blood, red blood cells, platelets, and plasma are among the cryopreserved items that blood banks keep in storage for a limited duration depending on the results of tests. Rise in the number of blood banks and blood infusion center leads to increase in demand for biomedical warming and thawing devices for cryopreserved items. Thus, this factor is anticipated to fuel the biomedical warming and thawing devices market growth. Moreover, surge in demand for blood donation fuels the demand for warming and thawing device in blood banks and blood infusion centers.
Globally, there is an increase in road traffic accidents that result in significant blood loss. One of the leading causes of mortality and morbidity in both, industrialized and developing nations are accidents. Patients who have suffered serious bleeding owing to their injuries in road accident need to get transfusions of red blood cells and blood components that have been cryopreserved. Thus, rise in the number of road traffic accidents is anticipated to boost the growth of biomedical warming devices market. In addition, increase in prevalence of infertility in male and female population cause rise in the demand for in-vitro fertilization. Stressed life and unhealthy style, late marriages, female disorder like polycystic ovary syndrome (PCOD) and male disorders premature ejaculation, and other causes lead to infertility. Thus, to conceive pregnancy, infertile population adopt technology like in-vitro fertilization. Rise in the number of in-vitro fertilization procedure cause increase in demand for cryopreserved embryo. Thus, this factor increases the demand for biomedical warming and thawing device for storage purpose, which fuels the market growth.
On the other hand, concerns about large batch sizes and strict regulatory guidelines relating to the use of cryopreserved and thawed biomedical products may have a detrimental influence on the market share for biomedical warming and thawing systems. Logistics and supply chain management were crucial in the shipping of cryopreserved biologics. The supply chain was disrupted as cryopreserved stem cells, blood products, and other products were unable to move freely during the pandemic, which further slowed the development of the biomedical thawing devices market.
Biomedical Warming And Thawing Devices Market Segmentation
The biomedical warming and thawing devices market share is segmented into product, sample type and end user. and region. On the basis of product, the market is segmented into manual and automatic. On the sample market is segmented into blood products, stem cells, embryo, ovum, and others. Blood products is further bifurcated into plasma, stem cells, whole blood & RBCs, and platelets. By end user, the market is bifurcated into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and blood banks & stem cell banks. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Segment Review
The automatic segment dominated the market in 2021, and is expected to remain dominant during the biomedical warming and thawing devices market forecast, owing to increase in the usage of automatic warming and thawing device for storage of cryopreserved items and effectiveness of device to store them.
The blood products segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to increase in the blood donation activity, rise in the prevalence of blood disorders, and increase in the number of blood banks. However, the stem cells segment is expected to witness considerable growth during the forecast period, owing to rise in the use of stem cells for treatment and research purpose, technological advancement in cell therapy and increase in R&D activities.
The hospitals & diagnostic laboratories segment dominated the market in 2021, and is expected to continue this trend during the forecast period, owing to rise in number of hospitals & diagnostic laboratories and increase in initiative taken by government to develop healthcare infrastructure. However, the blood banks & stem cell banks segment is expected to witness considerable growth during the forecast period, owing to increase in the number of blood banks & stem cell banks, rise in R&D activities, rise in blood donation activity, and increase in demand for cryopreserved blood products.
The North America market was dominant, in terms of revenue among other regions in 2021, owing to high presence of biomedical industry who manufacture biomedical warming and thawing device and technological advancement in the healthcare sector. On the other hand, Asia-Pacific was the second-largest contributor in the market in 2021, and is expected to register fastest CAGR during the forecast period, owing to increase in the activity of blood donation, rise in the number of blood banks and blood transfusion centers, and increase in expenditure by government to develop the healthcare sector.
Some of the major companies that operate in the global biomedical warming and thawing devices market include Barkey gmbh & Co. Kg, Boekel Scientific, Cardinal Health, Conroy Medical AB., Cytiva, CytoTherm, Eppendorf, Farrar Scientific, Fisher Scientific PTE LTD (Thermo Fisher Scientific), FreMon Scientific, Inc., GE, Helmer Scientific, KW Apparecchi Scientifici, Sarstedt AG & Co. KG, Sartorius AG, and Thaw World Medical Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biomedical warming and thawing devices market analysis from 2021 to 2031 to identify the prevailing biomedical warming and thawing devices market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the biomedical warming and thawing devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global biomedical warming and thawing devices market trends, key players, market segments, application areas, and market growth strategies.
Biomedical Warming and Thawing Devices Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Sample Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | ThawWorld Medical Ltd., FreMon Scientific, Inc., Sarstedt AG and Co. KG, BioLife Solutions, FISHER SCIENTIFIC PTE LTD, Helmer Scientific, General Electric Company, Farrar Scientific , Cytiva, KW APPARECCHI SCIENTIFICI, CARDINAL HEALTH, Conroy Medical AB., Barkey gmbh and co. kg, Eppendorf, BOEKEL SCIENTIFIC, Sartorius AG, CytoTherm |
Analyst Review
Biomedical warming and thawing devices aid in the warming and thawing of cryopreserved products, such as blood products, stem cells, embryo, ovum, and semen. Rise in the number of blood banks, increase in the in-vitro fertilization, and increase in the number of road accidents and trauma cases leading to blood transfusions are anticipated to fuel the market growth.
Rise in adoption of key strategies, such as collaboration, acquisition, agreement, and partnership by biomedical industry of biomedical warming and thawing devices manufacturers fuels the growth of the market. For instance, in July 2022, Azenta Inc., a leading provider of life science solutions, announced acquisition of Barkey Holding GmbH., which manufactures medical thawing and warming devices. This acquisition is for the enhancement of the Azenta Inc., position as one of the global leading life sciences companies with deep expertise in sample-based solutions and genomic services.
In addition, rise in the number of product approval for new technologies fuels the market growth. For instance, in September 2020, Boekel Scientific, a manufacturer of blood banking and laboratory equipment, announced the launch of FS100, a new high-capacity floor standing platelet incubator and agitator for storing platelets in hospitals and blood centers. The FS100 has 25 shelves with solid-state heating and cooling mechanism
The top companies that hold the market share in biomedical warming and thawing devices market are Barkey gmbh & Co. Kg, Boekel Scientific, Cardinal Health, Conroy Medical AB., Cytiva, CytoTherm, Eppendorf, Farrar Scientific, Fisher Scientific PTE LTD (Thermo Fisher Scientific), FreMon Scientific, Inc., GE, Helmer Scientific, KW Apparecchi Scientifici, Sarstedt AG & Co. KG, Sartorius AG, and Thaw World Medical Ltd
Asia-Pacific is expected to register highest CAGR of 10.0% from 2022 to 2031, owing to increase in the activity of blood donation, rise in the number of blood banks and blood transfusion centers, and increase in expenditure by government to develop the healthcare sector
The key trends in the biomedical warming and thawing devices market are increase in number of blood banks and blood infusion centers, rise in the number of road accidents and trauma cases leading to blood transfusions, and increase in adoption of in-vitro fertilization
The base year for the report is 2021.
Yes, biomedical warming and thawing devices market companies are profiled in the report
The total market value of biomedical warming and thawing devices market is $159.3 million in 2021.
The forecast period in the report is from 2022 to 2031
The market value of biomedical warming and thawing devices in 2022 was $172.4 million
Loading Table Of Content...
